Sable Therapeutics

Sable Therapeutics: An Early-Stage Biotechnology Company Developing Novel Fat-Reduction Therapies. The company’s product platform is unique, primarily focusing on reducing fat cells through lipid blocking and increased mitochondrial activity. Sable Therapeutics' commercial objectives include reducing visceral fat (obesity) and subcutaneous fat (cosmetic indications).